Company Overview
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.
Recent Developments
- Dec 2025 Revenue of $258.90M (+41.8% YoY); net profit $-40.07M.
- Trailing 12 Months Year-on-year growth — revenue +33.8%.
- 5-Year Trend Long-term compounding — revenue CAGR -25.0%, profit CAGR 2.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -25.00% |
| 1 Year: | 33.80% |
Compounded Profit Growth
| 5 Years: | 2.45% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -65.15% |
| 6 Months: | -78.44% |
| 3 Months: | -74.07% |
| 1 Month: | -12.55% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.49 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -25.0% CAGR over 5 years.
- Trading 92.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Technology).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ZEPP Zepp Health Corporation | 4.53 | -1.77 | $66.43M | 0.00% | -10.71% | -18.76% | -25.00% | 2.45% |
| 2 | NVDA NVIDIA Corporation NDXSPXAI | 200.75 | 30.79 | $4.86T | 0.47% | 74.66% | 114.29% | 24.64% | 32.12% |
| 3 | AAPL Apple Inc. NDXSPX | 308.91 | 37.35 | $4.54T | 0.37% | 68.72% | 141.47% | 1.81% | 3.92% |
| 4 | MSFT Microsoft Corporation NDXSPXAI | 464.72 | 28.15 | $3.45T | 0.95% | 26.90% | 34.01% | 9.48% | 10.85% |
| 5 | TSM Taiwan Semiconductor Manufacturing Company Limited AI | 404.25 | 35.09 | $2.10T | 0.90% | 30.20% | 36.21% | 18.94% | 19.57% |
| 6 | AVGO Broadcom Inc. NDXSPXAI | 389.28 | 64.13 | $1.85T | 0.68% | 16.70% | 37.28% | 24.38% | 26.24% |
| 7 | MU Micron Technology, Inc. NDXSPXAI | 823.03 | 18.60 | $929.52B | 0.05% | 13.69% | 66.64% | 13.68% | 26.02% |
| 8 | AMD Advanced Micro Devices, Inc. NDXSPXAI | 476.15 | 155.10 | $776.41B | 0.00% | 6.33% | 8.06% | 13.64% | 48.64% |
| 9 | ASML ASML Holding N.V. NDXAI | 1,629.00 | 53.66 | $627.85B | 0.51% | 42.97% | 52.24% | 15.55% | 19.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 38.54M | 59.41M | 75.79M | 85.17M | 51.55M |
| Cost of Revenue | - | 24.18M | 37.91M | 46.87M | 50.75M | 32.11M |
| Gross Profit | - | 14.36M | 21.49M | 28.92M | 34.41M | 19.44M |
| Operating Expenses | - | 32.74M | 27.59M | 29.81M | 38.29M | 37.13M |
| Operating Income | - | -18.38M | -6.10M | -884.00K | -3.87M | -17.69M |
| EBITDA | - | -17.91M | -5.75M | 218.00K | -6.32M | -17.34M |
| Interest Expense | - | 1.36M | 1.25M | 1.48M | 1.62M | 1.65M |
| Pretax Income | - | -19.27M | -6.99M | -1.26M | -7.94M | -18.99M |
| Tax Provision | - | 110.00K | 242.00K | 117.00K | 2.07M | 214.00K |
| Net Income | - | -19.74M | -7.74M | -1.62M | -10.97M | -19.64M |
| Diluted EPS | - | -1.28 | -0.48 | -1.60 | -0.64 | -1.28 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 613.64M | 352.86M | 182.60M | 258.90M |
| Cost of Revenue | - | 494.78M | 260.50M | 112.37M | 159.71M |
| Gross Profit | - | 118.86M | 92.36M | 70.23M | 99.19M |
| Operating Expenses | - | 180.71M | 122.81M | 117.48M | 128.42M |
| Operating Income | - | -61.86M | -30.45M | -47.25M | -29.23M |
| EBITDA | - | -38.74M | -20.19M | -47.34M | -25.23M |
| Interest Expense | - | 8.44M | 6.75M | 5.55M | 5.70M |
| Pretax Income | - | -55.89M | -34.63M | -57.90M | -35.46M |
| Tax Provision | - | -9.87M | -2.43M | 13.69M | 2.54M |
| Net Income | - | -43.24M | -31.02M | -75.73M | -40.07M |
| Diluted EPS | - | -2.71 | -1.96 | -4.64 | -2.56 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 763.50M | 635.52M | 528.59M | 564.84M |
| Current Assets | 428.82M | 316.73M | 251.56M | 293.52M |
| Cash & Equivalents | 128.51M | 133.67M | 91.07M | 57.05M |
| Inventory | 148.12M | 84.89M | 56.79M | 72.76M |
| Receivables | 98.87M | 60.73M | 62.97M | 66.91M |
| Total Liabilities | 374.35M | 282.77M | 275.87M | 350.30M |
| Current Liabilities | 241.86M | 155.11M | 195.37M | 286.84M |
| Long Term Debt | 99.17M | 120.02M | 75.24M | 59.48M |
| Total Debt | 250.27M | 195.77M | 182.14M | 228.96M |
| Total Equity | 387.36M | 350.88M | 251.59M | 214.53M |
| Shares Outstanding | 258.21M | 261.03M | 261.66M | 265.55M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -117.11M | 42.60M | -24.39M | -25.69M |
| Investing Cash Flow | - | -6.24M | 7.73M | -1.58M | 1.48M |
| Financing Cash Flow | - | 42.37M | -41.68M | 477.00K | 24.84M |
| Capital Expenditure | - | -1.47M | -1.68M | -1.49M | -784.00K |
| Free Cash Flow | - | -118.59M | 40.92M | -25.88M | -26.48M |
| Net Change in Cash | - | -80.98M | 8.65M | -25.49M | 623.00K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 19.4% | 26.2% | 38.5% | 38.3% |
| Operating Margin % | - | -10.1% | -8.6% | -25.9% | -11.3% |
| Net Margin % | - | -7.0% | -8.8% | -41.5% | -15.5% |
| ROE % | - | -11.2% | -8.8% | -30.1% | -18.7% |
| ROCE % | - | -11.9% | -6.3% | -14.2% | -10.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | FIL LTD | 8.48% | 717.35K | $3.25M |
| 2 | Morgan Stanley | 8.37% | 707.69K | $3.21M |
| 3 | Point72 Asset Management, L.P. | 6.83% | 577.68K | $2.62M |
| 4 | Millennium Management Llc | 4.05% | 342.50K | $1.55M |
| 5 | Price (T.Rowe) Associates Inc | 3.69% | 311.91K | $1.41M |
| 6 | Monolith Management Ltd | 2.05% | 173.85K | $787.53K |
| 7 | State Street Corporation | 1.50% | 127.11K | $575.80K |
| 8 | Goldman Sachs Group Inc | 1.39% | 117.80K | $533.65K |
| 9 | Balyasny Asset Management LP | 0.80% | 67.33K | $305.00K |
| 10 | Yiheng Capital Management, L.P. | 0.68% | 57.73K | $261.52K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ZEPP
ZEPP — Frequently Asked Questions
What is the current share price of Zepp Health Corporation (ZEPP)?
As of 2026-08-02 19:16 PDT, Zepp Health Corporation (ZEPP) trades at $4.53 on NYSE. Its 52-week range is $3.99 to $61.27.
What is the market capitalisation of ZEPP?
Zepp Health Corporation (ZEPP) has a market capitalisation of $66.43M on NYSE.
What is the P/E ratio of ZEPP?
ZEPP trades at a trailing price-to-earnings (P/E) ratio of -1.77. The industry average P/E is 34.58. Its price-to-book (P/B) ratio is 0.37.
What is the return on equity (ROE) of ZEPP?
ZEPP has a return on equity (ROE) of -18.76%. Its return on capital employed (ROCE) is -10.71%.
Is ZEPP a good stock to buy?
This page provides a data-driven analysis of Zepp Health Corporation (ZEPP), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.